David A. Santos

Insider Reports History

Entity
Individual
Location
Rigel Pharmaceuticals, Inc., 1180 Veterans Blvd., South San Francisco, CA
Signature
/s/ Raymond Furey (Attorney-in-Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David A. Santos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RIGEL PHARMACEUTICALS INC EVP, Chief Commercial Officer Common Stock 349K $398K $1.14 Feb 5, 2024 Direct
RIGEL PHARMACEUTICALS INC EVP, Chief Commercial Officer Employee Stock Option (right to buy) 78.5K Feb 28, 2024 Direct

Insider Reports Filed by David A. Santos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RIGL RIGEL PHARMACEUTICALS INC Feb 28, 2024 2 $0 4 Mar 1, 2024 EVP, Chief Commercial Officer
RIGL RIGEL PHARMACEUTICALS INC Feb 2, 2024 2 -$16.5K 4 Feb 6, 2024 EVP, Chief Commercial Officer
RIGL RIGEL PHARMACEUTICALS INC Jan 23, 2024 2 $0 4 Jan 25, 2024 EVP, Chief Commercial Officer
RIGL RIGEL PHARMACEUTICALS INC Feb 2, 2023 1 -$8.95K 4 Feb 6, 2023 EVP, Chief Commercial Officer
RIGL RIGEL PHARMACEUTICALS INC Jan 26, 2023 3 $0 4 Jan 30, 2023 EVP, Chief Commercial Officer
RIGL RIGEL PHARMACEUTICALS INC Dec 28, 2022 1 $0 4 Dec 30, 2022 EVP, Chief Commercial Officer
RIGL RIGEL PHARMACEUTICALS INC Jan 24, 2022 2 $0 4 Jan 26, 2022 EVP, Chief Commercial Officer